Results showed that sh-ATAD3A in Huh7 cells significantly increased the tumor weight and tumor volume compared to the control group in the presence of sorafenib treatment, and miR-210-5P antagomir reduced the tumor size and tumor volume both in control and sh-ATAD3A groups (Fig. 6i-l). Here, ATAD3A is linked to neoplasm.